賽隆藥業(002898.SZ):子公司簽訂國有建設用地使用權出讓合同
格隆匯 7 月 10日丨賽隆藥業(002898.SZ)公佈,此前公告披露同意子公司珠海賽隆國際投資有限公司參與競拍位於珠海市香洲區珠海大道南側、南灣大道西側國有建設用地使用權。2020年6月30日,珠海賽隆國際投資有限公司與珠海市公共資源交易中心簽訂了《珠海市公共資源交易中心成交確認書》,以總價人民幣3.29億元成功競拍取得該地塊的國有建設用地使用權。
近日,珠海賽隆國際投資有限公司與珠海市自然資源局簽訂了《國有建設用地使用權出讓合同》。宗地位置:珠海市香洲區珠海大道南側、南灣大道西側;宗地編號:珠自然資儲2020-09;用途:商業性辦公用地。
參與競拍國有建設用地使用權是為了落實公司與珠海市香洲區投資促進服務中心簽訂的《項目投資協議書》及與中信城開簽訂的《總部項目合作協議》,推進公司總部及研究院建設,對促進公司轉型升級有積極作用。此次國有建設用地使用權出讓合同的簽訂不會對公司經營及財務狀況產生重大影響。公司將根據相關事項進展情況及時履行信息披露義務,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.